Two Biosimilars Approved in Europe for Autoimmune Disorders

The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.

Related Keywords

Ukraine ,China ,Bulgaria ,Poland ,Georgia ,United States , ,European Union ,Medicinal Products ,Human Use ,European Medicines Agency ,Rheumatoid Arthritis Ra ,Heumatoid Arthritis Ra ,Psoriatic Arthritis ,Rthropathic Psoriasis ,Psoriatic Arthropathy ,Sa ,Arthritis ,Oint Inflammation ,Juvenile Rheumatoid Arthritis ,Uvenile Ra ,Juvenile Idiopathic Arthritis ,Crohn 039s Disease ,Crohn Disease ,Egional Enteritis Crohn S ,Psoriasis ,Europe ,European ,Biologic Therapy ,Iologics ,Covid 19 ,